1. Home
  2. ICCC vs YAAS Comparison

ICCC vs YAAS Comparison

Compare ICCC & YAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • YAAS
  • Stock Information
  • Founded
  • ICCC 1982
  • YAAS 2018
  • Country
  • ICCC United States
  • YAAS China
  • Employees
  • ICCC N/A
  • YAAS N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • YAAS Computer Software: Prepackaged Software
  • Sector
  • ICCC Health Care
  • YAAS Technology
  • Exchange
  • ICCC Nasdaq
  • YAAS Nasdaq
  • Market Cap
  • ICCC 61.3M
  • YAAS 59.0M
  • IPO Year
  • ICCC 1987
  • YAAS 2024
  • Fundamental
  • Price
  • ICCC $5.90
  • YAAS $3.03
  • Analyst Decision
  • ICCC
  • YAAS
  • Analyst Count
  • ICCC 0
  • YAAS 0
  • Target Price
  • ICCC N/A
  • YAAS N/A
  • AVG Volume (30 Days)
  • ICCC 27.4K
  • YAAS 44.0K
  • Earning Date
  • ICCC 08-12-2025
  • YAAS 06-27-2025
  • Dividend Yield
  • ICCC N/A
  • YAAS N/A
  • EPS Growth
  • ICCC N/A
  • YAAS N/A
  • EPS
  • ICCC N/A
  • YAAS N/A
  • Revenue
  • ICCC $27,302,766.00
  • YAAS $521,240.00
  • Revenue This Year
  • ICCC N/A
  • YAAS N/A
  • Revenue Next Year
  • ICCC N/A
  • YAAS N/A
  • P/E Ratio
  • ICCC N/A
  • YAAS N/A
  • Revenue Growth
  • ICCC 28.29
  • YAAS N/A
  • 52 Week Low
  • ICCC $3.34
  • YAAS $1.58
  • 52 Week High
  • ICCC $7.60
  • YAAS $4.25
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 50.09
  • YAAS N/A
  • Support Level
  • ICCC $6.14
  • YAAS N/A
  • Resistance Level
  • ICCC $6.58
  • YAAS N/A
  • Average True Range (ATR)
  • ICCC 0.25
  • YAAS 0.00
  • MACD
  • ICCC -0.07
  • YAAS 0.00
  • Stochastic Oscillator
  • ICCC 1.15
  • YAAS 0.00

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About YAAS Youxin Technology Ltd Class A Ordinary shares

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

Share on Social Networks: